GenFleet Therapeutics Funding: $343M Raised, Series B (2020)
GenFleet Therapeutics is based in Shanghai, China. It has raised $343M in total funding. Latest round: Series B.
GenFleet Therapeutics funding overview
GenFleet Therapeutics is based in Shanghai, China. GenFleet Therapeutics has raised $343M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in March 2020. The round record for GenFleet Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include CDH Investments, Shenzhen Capital Group, South China Venture Capital, Panlin Capital, Sinopharm Capital, Lakebleu Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
GenFleet Therapeutics at a glance
Total raised
$343M
Latest round
Series B
Latest round date
March 2020
Headquarters
Shanghai, China
Notable investors
CDH Investments, Shenzhen Capital Group, South China Venture Capital, Panlin Capital, Sinopharm Capital, Lakebleu Capital, Highlight Capital
Frequently asked about GenFleet Therapeutics funding
How much has GenFleet Therapeutics raised?
GenFleet Therapeutics has raised $343M in total disclosed funding across the rounds on record.
Who has invested in GenFleet Therapeutics?
CDH Investments, Shenzhen Capital Group, South China Venture Capital, Panlin Capital, Sinopharm Capital, Lakebleu Capital are named among the investors backing GenFleet Therapeutics.
What was the latest GenFleet Therapeutics funding round?
The most recent disclosed round is a Series B, announced in March 2020.
Where is GenFleet Therapeutics based?
GenFleet Therapeutics is based in Shanghai, China.
When did GenFleet Therapeutics last raise?
The last disclosed GenFleet Therapeutics round closed in March 2020 at Series B.
Every GenFleet Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Shanghai at a similar stage.
